News
Stem cells can produce any other cell type, it is just a matter of telling them in the right way. From a biological ...
Conference call and webcast rescheduled for 8:30 a.m. Eastern Time on Monday, May 19 NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
Fritz Lipmann Institute (FLI) in Jena have discovered a previously unknown function of immune cells in the bone marrow.
What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...
Scientists at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena discovered a previously unknown function of immune cells in the ...
IntroductionThe global mesenchymal stem cells market is witnessing a significant transformation as advancements in ...
BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...
"We were pleased that blinded data from the ongoing Phase 2 trial of BRTX-100 in cLDD continues to be in-line to meet the primary safety endpoint of study, and that the positive preliminary efficacy ...
People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may potentially allow people with type 2 diabetes to start producing more insulin ...
HiPSCs are very similar to embryonic stem cells, but they are generated by reprogramming adult cells collected from the connective ... Then we mix them with mesenchymal stem cells in a certain ratio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results